Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 188 entries
View as:

Research of Biomarkers of Response to Proton Beam Therapy in Pediatric and Adult Patients.

Phase: N/A Priority: Normal
NCT ID: NCT04367779 Org: User:
Start: 09/24/20 End: 06/30/24 Due: 06/30/25

Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST)

Phase: N/A Priority: Normal
NCT ID: NCT01323400 Org: User:
Start: 03/31/11 End: 02/29/16 Due: 02/28/17

Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT)

Phase: N/A Priority: Normal
NCT ID: NCT01261429 Org: User:
Start: 12/31/10 End: 04/30/13 Due: 04/30/14

GastrOesophageal Tumor, Immune Microenvionnment (GOTIM)

Phase: N/A Priority: Normal
NCT ID: NCT05644431 Org: User:
Start: 07/19/23 End: 01/15/28 Due: 01/15/29

Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment

Phase: N/A Priority: Normal
NCT ID: NCT02029001 Org: User:
Start: 03/31/14 End: 10/31/27 Due: 10/31/28

Satisfaction and Quality of Life Comparison Between Patients Using Cicaplast Baume B5 Versus Dexeryl for the Management of Cutaneous Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors (iEGFR)

Phase: N/A Priority: Normal
NCT ID: NCT03421912 Org: User:
Start: 02/16/18 End: 05/11/21 Due: 05/11/22

Evaluation of the Oncoral® Test in Epidermoid Carcinomas of the Upper Aerodigestive Tract

Phase: N/A Priority: Normal
NCT ID: NCT01361100 Org: User:
Start: 12/31/10 End: 06/30/15 Due: 06/30/16

FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum

Phase: N/A Priority: Normal
NCT ID: NCT06393816 Org: User:
Start: 06/13/24 End: 09/30/29 Due: 09/30/30

Lifestyle Intervention Among Participants of the French Colorectal Cancer Screening Program (LIFE-SCREEN)

Phase: N/A Priority: Normal
NCT ID: NCT06827366 Org: User:
Start: 02/15/25 End: 02/15/27 Due: 02/15/28

Impact of a Multidisciplinary End-of-treatment Day Hospital on the Quality of Life of Adolescents and Young Adults with Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05858424 Org: User:
Start: 11/29/22 End: 09/30/25 Due: 09/30/26

Prospective Multicentre Study of the Use of Ketamine in the Treatment of Refractory Chronic Pain in the French CLCC

Phase: N/A Priority: Normal
NCT ID: NCT04459234 Org: User:
Start: 02/02/21 End: 03/09/23 Due: 03/09/24

Lung Ultrasound Score After ENT Cancer Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05482841 Org: User:
Start: 12/01/22 End: 01/31/25 Due: 01/31/26

Stereotactic Body Radio Therapy (SBRT) for Early-stage Non Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00870116 Org: User:
Start: 04/30/09 End: 03/31/13 Due: 03/31/14

Prognostic Value of Divpenia and CD4 Count in Relapsed Breast or Lung Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01306188 Org: User:
Start: 07/31/10 End: 12/31/14 Due: 12/31/15

Measurement of Implant Stability by Resonance Frequency Analysis in Patients Treated for an Upper Aero-digestive Tract Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04532359 Org: User:
Start: 02/05/21 End: 03/01/24 Due: 03/01/25

Multiparametric Quantitative MRI and Response to Neoadjuvant Radiotherapy for Soft-tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT05684874 Org: User:
Start: 04/21/23 End: 01/31/24 Due: 01/31/25

Stereotactic Prostate Radiotherapy With Dose Escalation Focused on the "Dominant Intra-prostatic Lesion" (DIPL) Delineated by Multi-parametric MRI and 68Ga-PSMA PET (Prostate-SIB-PSMA)

Phase: N/A Priority: Normal
NCT ID: NCT05599737 Org: User:
Start: 05/24/22 End: 05/25/24 Due: 05/25/25

Evaluation of the Added Value of a Large Molecular Profiling Panel Versus a Limited Molecular Profiling Panel in Advanced Solid Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT03163732 Org: User:
Start: 06/29/17 End: 11/23/21 Due: 11/23/22

Heterogeneity of Oral Squamous Cell Carcinoma Analysis by Single Cell RNA Sequencing

Phase: N/A Priority: Normal
NCT ID: NCT06861036 Org: User:
Start: 05/15/25 End: 05/15/28 Due: 05/15/29

A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined with Atezolizumab Versus Imatinib Resumption Alone in Patients with Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments

Phase: N/A Priority: Normal
NCT ID: NCT05152472 Org: User:
Start: 01/14/22 End: 10/31/27 Due: 10/31/28

Tobacco, Alcohol and Cancerization of the Oral Mucosa (TACO)

Phase: N/A Priority: Normal
NCT ID: NCT06425146 Org: User:
Start: 08/09/24 End: 09/15/25 Due: 09/15/26

Study of the Efficacy of Lenvatinib Combined With Denosumab in the Treatment of Patients With Predominant Bone Metastatic Radioiodine Refractory Differentiated Thyroid Carcinomas

Phase: N/A Priority: Normal
NCT ID: NCT03732495 Org: User:
Start: 07/26/19 End: 01/15/23 Due: 01/15/24

Gene Signatures Searching of Sensitivity/Resistance to Neoadjuvant Radiotherapy in Patients With Resectable STS

Phase: N/A Priority: Normal
NCT ID: NCT05739084 Org: User:
Start: 11/23/22 End: 11/23/25 Due: 11/23/26

Interest of PET-PSMA Imaging Potentialised by Androgen Blockade in Localized Prostatic Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04391556 Org: User:
Start: 09/14/20 End: 04/03/24 Due: 04/03/25

COLON-IM : Microbiota and Immune Infiltrate in Normal, Dysplastic and Neoplastic Colorectal Tissue

Phase: N/A Priority: Normal
NCT ID: NCT03841799 Org: User:
Start: 05/02/19 End: 12/31/29 Due: 12/31/30